New treatments in ulcer healing and wound infection

Citation
M. Edmonds et al., New treatments in ulcer healing and wound infection, DIABET M R, 16, 2000, pp. S51-S54
Citations number
18
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
DIABETES-METABOLISM RESEARCH AND REVIEWS
ISSN journal
15207552 → ACNP
Volume
16
Year of publication
2000
Supplement
1
Pages
S51 - S54
Database
ISI
SICI code
1520-7552(200009/10)16:<S51:NTIUHA>2.0.ZU;2-F
Abstract
This review examines several of the recently introduced wound care products that have been put forward as treatment modalities for the diabetic foot u lcer. Discussed are the results of clinical trials with the platelet-derive d growth factor, becaplermin, the tissue-engineered products Dermagraft and Apligraf, and Hyaff which is an ester of hyaluronic acid. In patients with an infected foot ulcer, encouraging results were obtained with the granulo cyte-colony stimulating factor, Filgrastim. Copyright (C) 2000 John Wiley & Sons, Ltd.